C. Maillard

发表

Digging deeper into lymphatic vessel formation in vitro and in vivo

J. Foidart, A. Noël, M. Thiry, 2011, BMC Cell Biology.

Altered α‐defensin 5 expression in cervical squamocolumnar junction: implication in the formation of a viral/tumour‐permissive microenvironment

J. Foidart, A. Noël, P. Delvenne, 2014, The Journal of pathology.

Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth

P. Carmeliet, J. Foidart, A. Gils, 2004, Oncogene.

Host plasminogen activator inhibitor-1 promotes human skin carcinoma progression in a stage-dependent manner.

P. Carmeliet, J. Foidart, C. Munaut, 2005, Neoplasia.

Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters.

J. Foidart, J. Rosing, C. Klipping, 2020, Contraception.

Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot study

J. Foidart, H. C. Coelingh Bennink, C. Klipping, 2015, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Modelling Lymphatic and blood capillary patterning

A. Noël, F. Bruyére, Charlotte Erpicum, 2012 .

Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis.

J. Foidart, J. Martial, Y. DeClerck, 2008, Cancer cell.

Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives

J. Foidart, H. C. Coelingh Bennink, C. Klipping, 2015, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Effects of fatty acid synthase inhibitors on lymphatic vessels: an in vitro and in vivo study in a melanoma model

A. Noël, R. Coletta, E. Graner, 2017, Laboratory Investigation.

Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone.

J. Foidart, C. Klipping, C. Maillard, 2021, Contraception.

Defensins induce the recruitment of dendritic cells in cervical human papillomavirus-associated ( pre ) neoplastic lesions formed in vitro and transplanted in vivo

P. Delvenne, A. Nikkels, G. Piérard, 2007 .

Delivery of Granulocyte-Macrophage Colony-Stimulating Factor in Bioadhesive Hydrogel Stimulates Migration of Dendritic Cells in Models of Human Papillomavirus-Associated (Pre)Neoplastic Epithelial Lesions

J. Foidart, A. Noël, P. Delvenne, 2004, Antimicrobial Agents and Chemotherapy.

Higher sensitivity of Adamts 12-deficient mice to tumor growth and angiogenesis

J. Foidart, C. López-Otín, S. Cal, 2009 .

Histology of the vaginal wall in women with pelvic organ prolapse: a literature review

J. Foidart, C. Munaut, M. Nisolle, 2013, International Urogynecology Journal.

N-Hydroxy-6-(5-Nitro- Naphtalimide)-Hexanamide Inhibits Lysine Deacetylation, Mitigates Angiogenesis and Reduces Tumor Growth

A. Noël, P. Delvenne, J. Wouters, 2015 .

Sunitinib inhibits inflammatory corneal lymphangiogenesis.

J. Rakic, V. Lambert, J. Foidart, 2013, Investigative ophthalmology & visual science.

Higher sensitivity of Adamts12-deficient mice to tumor growth and angiogenesis

J. Foidart, C. López-Otín, S. Cal, 2010, Oncogene.

Contribution of host MMP‐2 and MMP‐9 to promote tumor vascularization and invasion of malignant keratinocytes

S. Itohara, J. Foidart, A. Noël, 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Tumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type I.

J. Rakic, V. Lambert, P. Carmeliet, 2007, The American journal of pathology.

Membrane associated proteases and their inhibitors in tumour angiogenesis

J. Foidart, A. Noël, A. Noel, 2004, Journal of Clinical Pathology.

Role of plasminogen activator-plasmin system in tumor angiogenesis

J. Rakic, V. Lambert, L. Devy, 2003, Cellular and Molecular Life Sciences CMLS.

The angiostatic protein 16K human prolactin significantly prevents tumor-induced lymphangiogenesis by affecting lymphatic endothelial cells.

A. Noël, J. Martial, S. Blacher, 2011, Endocrinology.

Bleeding pattern and cycle control with estetrol-containing combined oral contraceptives: results from a phase II, randomised, dose-finding study (FIESTA).

J. Foidart, D. Apter, H. C. Coelingh Bennink, 2016, Contraception.

Matrix metalloproteinase-2 governs lymphatic vessel formation as an interstitial collagenase.

V. Lambert, P. Carmeliet, J. Foidart, 2012, Blood.

Reduction of brain metastases in plasminogen activator inhibitor-1-deficient mice with transgenic ocular tumors.

J. Foidart, A. Noël, P. Opolon, 2008, Carcinogenesis.

Estetrol combined with drospirenone: an oral contraceptive with high acceptability, user satisfaction, well-being and favourable body weight control

J. Foidart, D. Apter, H. C. Coelingh Bennink, 2017, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Unimpeded skin carcinogenesis in K14‐HPV16 transgenic mice deficient for plasminogen activator inhibitor

J. Foidart, A. Noël, P. Delvenne, 2011, International journal of cancer.

Does Plasminogen Activator Inhibitor-1 Drive Lymphangiogenesis?

V. Lambert, J. Foidart, A. Noël, 2010, PloS one.